Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Other financing activities (2020 - 2024)

RxSight filings provide 5 years of Other financing activities readings, the most recent being -$768000.0 for Q4 2024.

  • On a quarterly basis, Other financing activities fell 7081.82% to -$768000.0 in Q4 2024 year-over-year; TTM through Dec 2025 was -$377000.0, a N/A change, with the full-year FY2023 number at $2.2 million, up 1441.38% from a year prior.
  • Other financing activities hit -$768000.0 in Q4 2024 for RxSight, down from $391000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.6 million in Q3 2023 to a low of -$768000.0 in Q4 2024.
  • Median Other financing activities over the past 5 years was $142000.0 (2022), compared with a mean of $204466.7.
  • Biggest five-year swings in Other financing activities: skyrocketed 960.13% in 2023 and later plummeted 7081.82% in 2024.
  • RxSight's Other financing activities stood at $687000.0 in 2020, then plummeted by 135.23% to -$242000.0 in 2021, then skyrocketed by 38.02% to -$150000.0 in 2022, then surged by 107.33% to $11000.0 in 2023, then plummeted by 7081.82% to -$768000.0 in 2024.
  • The last three reported values for Other financing activities were -$768000.0 (Q4 2024), $391000.0 (Q3 2024), and $377000.0 (Q2 2024) per Business Quant data.